Analysis on the difference between the payment limitations of anti-cancer drugs and the application scope of drug indications
Comparative analysis of antibacterial drugs between the 2021 edition of WHO Model List of Essential Medicines for Children and the 2018 edition of National Essential Medicines List of China
Strategic exploration of the implementation of China’s drug patent linkage system corresponding to international rules
Related Author
邓一农 郭春霞 王 梅
吕亚军?蚩晓娜?谷志勇
ZHAO Dehua
LONG Xiaoqing
WANG Jisheng
FAN Hongying
LIU Yang
ZHANG Jinfen
Related Institution
Dept. of Clinical Pharmacy, the Third People’s Hospital of Mianyang (Sichuan Mental Health Center)
Dept. of Pharmacy, Tianjin Children’s Hospital/Tianjin University Children’s Hospital
Scientific Research Institute of Drug Administration, China Pharmaceutical University/Key Laboratory for Drug Regulatory Innovation and Evaluation, National Medical Products Administration